- Login
- Register
- Home/Current Issue
- About the journal
- Editorial board
- Online submission
- Instructions for authors
- Subscriptions
- Foundation Acta Endocrinologica
- Archive
- Contact
Romanian Academy
The Publishing House of the Romanian Academy
ACTA ENDOCRINOLOGICA (BUC)
The International Journal of Romanian Society of Endocrinology / Registered in 1938in Web of Science Master Journal List
Acta Endocrinologica(Bucharest) is live in PubMed Central
Journal Impact Factor - click here.
This Article
Services
Google Scholar
PubMed
Acta Endocrinologica (Buc)
Sari F, Ozdem S, Sari R
Serum 25-Hydroxyvitamin D(3) Levels in Type 2 Diabetic Patients with Normo-, Micro-, and Macroalbuminuria
Acta Endo (Buc) 2016, 12 (3): 303-308doi: 10.4183/aeb.2016.303
Background. The aim of this study was to observe
the differences in serum 25-hydroxyvitamin D(3) levels in
nondiabetic healthy control subject and type 2 diabetic patients,
and to investigate the differences in serum 25-hydroxyvitamin
D(3) levels in type 2 diabetic patients with normo-, micro- and
macroalbuminuria.
P atients and Methods. Total 140 nondiabetic
healthy controls and 384 type 2 diabetic patients
(156 normoalbuminuric, 152 microalbuminuric and
76 macroalbuminuric) were included in the study.
25-hydroxyvitamin D(3) levels were measured in sera with
the method of electrochemiluminescence using modular
immunoassay analyzer.
Results. Vitamin D deficiency was detected in
70.85% and 22.9% of type 2 diabetic patients and nondiabetic
healthy controls, respectively. Serum 25-hydroxyvitamin
D(3) levels were significantly lower in type 2 diabetic patients
compared to nondiabetic healthy controls (16.4 ± 9.5 ng/mL vs.
28.2 ± 11.6 ng/mL, p=0.0001). Serum 25-hydroxyvitamin D(3)
levels were lower in albuminuric and nonalbuminuric diabetic
patients (14.3 ± 7.9 ng/mL vs. 19.6±10.9 ng/mL, respectively,
p=0.013). Serum 25-hydroxyvitamin D(3) levels were 19.6
± 10.9 ng/mL in normoalbuminuric, 14.9 ± 8.8 ng/mL in
microalbuminuric and 12.9 ± 5.8 ng/mL in macroalbuminuric
diabetic patients. While lower serum 25-hydroxyvitamin D(3)
levels were detected both in microalbuminuric (p=0.028) and
macroalbuminuric diabetic patients (p=0.014) compared to
normoalbuminuric diabetic patients, 25-hydroxyvitamin D(3)
levels did not change significantly between microalbuminuric
and macroalbuminuric diabetic patients (p=0.67). Serum
25-hydroxyvitamin D(3) levels correlated negatively with
urinary albumin excretion (r=-0.24, p=0.016) in patients with
diabetes mellitus.
Conclusion. Findings of the present study
demonstrated reduced serum 25-hydroxyvitamin D(3) levels
which were significantly related with albuminuria in type 2
diabetic patients.
Keywords: Vitamin D, diabetes mellitus, albuminuria.
Correspondence: Ramazan Sari MD, Akdeniz University, Endocrinology and Metabolism, Akdeniz University, School of Medicine, Antalya, TR-07070, Turkey, E-mail: drsari@hotmail.com